Title:
放射性医薬
Document Type and Number:
Japanese Patent JP7370520
Kind Code:
B2
Abstract:
One embodiment of the present invention relates to novel substances, etc., which are: [1] a compound, etc., represented by formula (A1) or formula (B1); [2] a compound, etc., represented by formula (A2) or formula (B2); [3] a compound, etc., represented by formula (A3) or formula (B3); [4] a compound, etc., represented by formula (A4) or formula (B4); [5] a radioactive pharmaceutical including the compound. etc., described in [1] or [2]; [6] a radiotherapeutic agent including the compound, etc., described in [1] or [2]; [7] a radiographic imaging diagnostic agent including the compound, etc., described in [1] or [2]; [8] a use of the compound, etc., described in [1] or [2], for production of radioactive pharmaceuticals; and [9] a medical agent, etc., for preparation of radioactive pharmaceuticals, including the compound, etc., described in [1] or [2].
More Like This:
Inventors:
Wilderness Tai
Tomoya Uehara
Hiromoto Suzuki
Hiroshi Tanaka
Noriko Ishioka
Shigeki Watanabe
Tomoya Uehara
Hiromoto Suzuki
Hiroshi Tanaka
Noriko Ishioka
Shigeki Watanabe
Application Number:
JP2019569541A
Publication Date:
October 30, 2023
Filing Date:
January 31, 2019
Export Citation:
Assignee:
National University Corporation Chiba University
National Institute for Quantum Science and Technology
National Institute for Quantum Science and Technology
International Classes:
C07C43/178; A61K31/225; A61K31/255; A61K31/357; A61K31/4025; A61K31/4178; A61K31/4192; A61K31/437; A61K38/06; A61K51/04; A61K51/08; A61P35/00; C07B59/00; C07C275/16; C07D319/06; C07D405/06; C07D405/12; C07D471/04; C07K5/06
Domestic Patent References:
| JP2015081242A | ||||
| JP2017052713A |
Foreign References:
| WO2013042668A1 |
Attorney, Agent or Firm:
Patent Attorney Corporation Otani Patent Office